FFWA
VRTX icon

FRG Family Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

FRG Family Wealth Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.41M Hold
3,150
– – 0.23% 72
2025
Q4 		$1.43M Sell
3,150
-30
-0.9% -$12.9K 0.22% 71
2025
Q3 		$1.25M Buy
3,180
+100
+3% +$41.8K 0.2% 75
2025
Q2 		$1.37M Sell
3,080
-50
-2% -$23K 0.24% 67
2025
Q1 		$1.52M Sell
3,130
-105
-3% -$48.9K 0.29% 55
2024
Q4 		$1.3M Buy
3,235
+30
+0.9% +$13.9K 0.24% 65
2024
Q3 		$1.49M Sell
3,205
-12
-0.4% -$5.76K 0.27% 60
2024
Q2 		$1.53M Hold
3,217
– – 0.3% 54
2024
Q1 		$1.26M Sell
3,217
-75
-2% -$31.7K 0.25% 63
2023
Q4 		$1.34M Hold
3,292
– – 0.27% 59
2023
Q3 		$1.14M Buy
3,292
+30
+0.9% +$10.5K 0.26% 65
2023
Q2 		$1.15M Buy
3,262
+10
+0.3% +$3.37K 0.25% 65
2023
Q1 		$1.02M Sell
3,252
-245
-7% -$73.5K 0.23% 75
2022
Q4 		$1.01M Hold
3,497
– – 0.24% 77
2022
Q3 		$1.01M Sell
3,497
-43
-1% -$12.4K 0.25% 67
2022
Q2 		$998K Buy
3,540
+100
+3% +$26.8K 0.23% 72
2022
Q1 		$898K Buy
3,440
+20
+0.6% +$4.75K 0.17% 79
2021
Q4 		$751K Buy
3,420
+215
+7% +$41.8K 0.14% 86
2021
Q3 		$581K Buy
3,205
+145
+5% +$28.3K 0.11% 96
2021
Q2 		$617K Buy
+3,060
New +$640K 0.12% 96

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

FRG Family Wealth Advisors's VRTX Position: Q1 2026 in Review

FRG Family Wealth Advisors held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 3,150 shares worth $1.41M. The position accounts for 0.23% of the portfolio, ranked #72.

FRG Family Wealth Advisors first reported a position in VRTX in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.53M in Q2 2024. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • FRG Family Wealth Advisors held 3,150 shares of Vertex Pharmaceuticals worth $1.41M as of Q1 2026.
  • FRG Family Wealth Advisors left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
  • Vertex Pharmaceuticals made up 0.23% of FRG Family Wealth Advisors's portfolio in Q1 2026, its #72 holding.
  • FRG Family Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • FRG Family Wealth Advisors's Vertex Pharmaceuticals position peaked at $1.53M in Q2 2024.
  • 1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on FRG Family Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.